Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details)

v3.22.2.2
Related Party Transactions (Details)
3 Months Ended 9 Months Ended
Apr. 08, 2022
USD ($)
shares
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Director
shares
Sep. 30, 2021
USD ($)
Pre-Merger Financing and Waiver Agreements [Abstract]          
Number of directors signed waiver agreements | Director       6  
Director [Member]          
Pre-Merger Financing and Waiver Agreements [Abstract]          
Consulting fee payable in cash | $ $ 10,000        
Number of stock option granted (in shares) 50,000        
Vesting period       36 months  
Consulting expenses | $   $ 30,000 $ 0 $ 60,000 $ 0
Consulting expenses unpaid | $   $ 10,000   $ 10,000  
Director [Member] | Vesting on March 31, 2023 [Member]          
Pre-Merger Financing and Waiver Agreements [Abstract]          
Vesting percentage 25.00%        
Pre-Merger Financing [Member]          
Pre-Merger Financing and Waiver Agreements [Abstract]          
Number of directors | Director       5  
Amount invested in pre-merger financing | $       $ 300,000  
Number of converted initial shares received by directors (in shares)   17,729   17,729  
Number of converted additional shares (in shares)   53,189   53,189  
Pre-Merger Financing [Member] | Rexahn [Member]          
Pre-Merger Financing and Waiver Agreements [Abstract]          
Number of directors | Director       1  
Pre-Merger Financing [Member] | Series A Warrants [Member]          
Pre-Merger Financing and Waiver Agreements [Abstract]          
Number of converted additional shares (in shares)   80,366   80,366  
Pre-Merger Financing [Member] | Series B Warrants [Member]          
Pre-Merger Financing and Waiver Agreements [Abstract]          
Number of converted additional shares (in shares)   9,444   9,444